Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jim Faulkner"'
Autor:
Vijay G R Peddareddigari, Simon Thomas, Jim Faulkner, Sonja Zweegman, Tobias Menne, Ekaterini Kotsopoulou, Lydia Lee, Shaun Cordoba, Martin Pule, Virginie Cerec, Kwee Yong, Nushmia Z. Khokhar, Jim Cavet, Muhammad Al-Hajj, Rakesh Popat
Publikováno v:
Blood. 134:3112-3112
Introduction: Chimeric antigen receptor (CAR) T cell therapies directed against B cell maturation antigen (BCMA) have shown significant activity in patients with RRMM, however single antigen targeting with CAR-T cells can result in antigen negative r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::694331aef57a5c0e4e2b7dca060dc092
https://doi.org/10.1182/blood-2019-126689
https://doi.org/10.1182/blood-2019-126689
Autor:
Vijay G R Peddareddigari, Martin Pule, Muhammad Al-Hajj, Robert T. Chen, Nushmia Z. Khokhar, Maria A V Marzolini, Simon Thomas, Kirit M. Ardeshna, Wendy Osborne, Jane Norman, Maud Jonnaert, Jim Faulkner, Ekaterini Kotsopoulou
Publikováno v:
Blood. 134:246-246
Introduction: CD 19 CAR T cell therapies have shown significant activity in patients with r/r DLBCL, however relapses due to CD19 loss or PDL1 upregulation are common. In this study, we are evaluating the safety and efficacy of AUTO3, a CAR T cell th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::880c4fa04a72aea9f9ae4d37fe3fa0dd
https://doi.org/10.1182/blood-2019-122724
https://doi.org/10.1182/blood-2019-122724
Autor:
Megan Holden, Linda M. Harvey, Jim Faulkner, Mariana L. Fazenda, Alison Nordon, Brian McNeil, Julian Morris, David Littlejohn, Zeng-Ping Chen, Li-Jing Zhong
Publikováno v:
Analytical Chemistry. 83:2655-2659
Large-scale commercial bioprocesses that manufacture biopharmaceutical products such as monoclonal antibodies generally involve multiple bioreactors operated in parallel. Spectra recorded during in situ monitoring of multiple bioreactors by multiplex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17c73a555d7af5877b31ed7ba088c09
https://doi.org/10.1021/ac103145a
https://doi.org/10.1021/ac103145a
Autor:
Martin Pule, Maria A V Marzolini, Wendy Osborne, Muhammad Al-Hajj, Nushmia Z. Khokhar, Kirit M. Ardeshna, Simon Thomas, Jim Faulkner, Vijay G R Peddareddigari
Publikováno v:
Blood. 132:1679-1679
Introduction CAR T-cell therapies directed against CD19 have shown significant activity in patients with r/r DLBCL; however, a significant number of patients relapse due to target antigen loss or upregulation of PDL1. In this study, we evaluate the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6193bb03fc5cb2808fdc2e114fc6e4a
https://doi.org/10.1182/blood-2018-99-119197
https://doi.org/10.1182/blood-2018-99-119197
Autor:
Jim, Faulkner
Publikováno v:
Survival news (Atlanta, Ga.). 16(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a2b2f82d0afd18586cf62e7b3ebd4e97
https://pubmed.ncbi.nlm.nih.gov/16106552
https://pubmed.ncbi.nlm.nih.gov/16106552
Autor:
Valerie S. Hall, Jim Faulkner, Mark Uden, Michael J. Molloy, Susannah I. Bailey, Katharine J. Griffin
Within the biopharmaceutical industry, recombinant plasmid DNA is used both as a raw material (e.g. in lentiviral and AAV vector production) as well as an active ingredient (e.g. in DNA vaccines). Consequently, many analytical laboratories are routin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fab5141bd3c54b8788416f146f80ef3
https://europepmc.org/articles/PMC519125/
https://europepmc.org/articles/PMC519125/
